Has James Germano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $663,476 in general payments to James Germano, MD across 365 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Germano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Germano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Germano, MD

Orthopaedic Surgery · Rockville Centre, NYNPI 1811048838

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (49.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Encore Medical, LP at 49.2% of the total. Reporting peaked in 2021 at $356,752 and has fallen 70.3% since, to $106,013 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$663,476in general payments, 2019–2025

Across 365 payments — averaging $1817.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Encore Medical, LP$326K
Medical Device Business Services, Inc.$217K
Stryker$90K
Depuy Synthes Products, Inc.$26K
Johnson & Johnson$2K
Next Science LLC$680
plus $2K from 7 others

$57,978in research payments, 2019–2025

Across 7 payments — averaging $8282.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$58K

What the payments were for

Consulting fees$301,09845%
Travel & lodging$21,2923%
Food & beverage$14,8632%
Other$326,22349%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Encore Medical, LP	1	$326,223
Medical Device Business Services, Inc.	114	$217,076
Stryker	158	$89,862
Depuy Synthes Products, Inc.	41	$26,154
Johnson & Johnson	28	$1,778
Next Science LLC	6	$680
Zimmer Biomet	5	$503
Linvatec Corporation	6	$490
Amgen	2	$288
Polaris Technology Solutions LLC	1	$157
Heron Therapeutics, Inc.	1	$119
Smith+Nephew	1	$112
Nevro Corp.	1	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RECLAIM$178,088
PINNACLE$172,832
Pinnacle Gription TF$144,022
Pinnacle Gription$143,878
MAKO$74,280
ATTUNE$29,182
GRIPTION$28,688
GRIPTION TF$28,688
LPS$26,246
S-ROM NOILES$26,246
ACTIS$9,414
Velys$7,028
TRIATHLON$6,580
CORAIL$2,801
ACCOLADE$1,692
TRITANIUM$1,400
INSIGNIA$667
SurgX$405
Xperience$405
BlastX$405

How this compares

$663,476 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$1,029,774

Medicare patients

969

Services billed

27,636

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol	16	$1,896
Celecoxib	25	$1,209
Meloxicam	344	$1,110
Diclofenac Sodium	17	$344
Methylprednisolone	42	$299
Gabapentin	19	$171
Cyclobenzaprine Hcl	18	$114
Ibuprofen	16	$76
Amoxicillin	26	$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rockville Centre

Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →